Dental extraction is performed frequently and can be accompanied by perioperative or postoperative complications. Bleeding is among the most common and important issues to consider in the ...

PARIS, France—After TAVR, patients prescribed single antiplatelet therapy are less likely to report a major adverse event at 3 months than those on dual antiplatelet therapy, according to results of ...

WASHINGTON, DC—Compared with dual antiplatelet therapy (DAPT), taking a single antiplatelet following TAVI is associated with a lower rate of all-cause mortality and major bleeding at 6 months, ...

Some patients with a common type of stroke benefit from a clot-busting drug given between 4.5 and 24 hours after symptoms emerged, according to a new study.

Dual antiplatelet therapy after heart bypass surgery is not more effective than aspirin alone - and it increases the risk of excessive bleeding. This has now been shown in a study of 2,201 patients at ...

Please provide your email address to receive an email when new articles are posted on . Single antiplatelet therapy was tied to lower 6-month mortality risk vs. dual antiplatelet therapy after ...

Antiplatelet therapy is a key component in the management of many medical diseases to decrease the risk of cardiovascular events.1 Acetylsalicyclic acid (ASA) is the most common antiplatelet agent ...

Treatment guidelines say patients who undergo minimally invasive aortic heart valve replacements should receive two antiplatelet drugs to reduce the risk of dangerous blood clots. A new study has ...

DALLAS -- Dual antiplatelet therapy (DAPT) proved non-inferior to IV alteplase in Chinese patients with minor non-disabling stroke, a researcher reported. In the ARAMIS trial of patients with acute ...

There was no benefit to modulating the intensity of antiplatelet therapy compared with standard antiplatelet therapy in high-risk patients who had undergone complex stenting procedures, according to ...

Although seemingly inappropriate, antiplatelet therapy could benefit patients who have survived intracerebral hemorrhage (ICH) and are therefore at risk of recurrent ICH. The decision to prescribe ...